Nextmune
Your global partner for pet specialty healthcare
A science-driven, speciality pharma company dedicated to allergy, dermatology and specialised nutrition
Global #1
In allergy testing and
allergy immunotherapy
70+
Sales in more than
70 countries
Premium offering
‘Gold standard’ allergy test and treatment
Evidence-based dermatology and nutrition
Global capabilities
Rapid turnaround time
Support & Expertise
Access to leading KOLs worldwide
Derm. / allergy veterinarians in Customer Service
GMP&USDA
GMP and USDA-certified facilities in Europe and US
Molecular Allergology: The future of IgE sensitisation detection
With CCD blocking and 2 blocking efficiency detectors
First quantitative multiplex macroarray specifically designed for companion animals
Expected increase in serological test sensitivity due to a higher concentration of molecular allergens
Over 200 allergen components + extracts included
= lower testing cost per allergen
Fully automated process = higher level of standardization
Only 0.5 ml of serum needed
Identification of ”primary” sensitizing allergens
Identification of allergen cross-reactivities
Selection of relevant allergens for specific immunotherapy
Animal becomes
less sensitive or
even insensitive
to allergens
Only causal treatment for atopic dogs, cats
and horses
Licensed ASIT:
product of choice
Safe for long-term
treatment: virtually no
side effects
Tailor-made for
each individual
patient
®
Dogs
Cats
Horses
75%
70%
84%
Treatment
Allergen-specific immunotherapy
*Licensed in NL
Nextmune eye on patient, mind on innovation
UK
DE / AT / CH
ES / PT
NO / SE/ DK
Italy
+44 01494 629979
+49 4554 716 1237
+34 914 134 472
+47 62 83 29 00
+39 0373 982024
vetenquiries.uk@nextmune.com
info.de@nextmune.com
info.es@nextmune.com
post.no@nextmune.com
info.it@nextmune.com
NL / BE
+31 320 783 100
info.nl@nextmune.com
France
Export
+33 1 70 61 48 38
+31 320 783 100
info.fr@nextune.com
info.eu@nextmune.com
post.se@nextmune.com
post.dk@nextmune.com
[EN] - Webinar intro presentation
By Nextmune
